Dr. David Zimmerman PharmD

President/Owner, Doctors of Pharmacy, Inc.

GLG News by Dr. David Zimmerman PharmD, President/Owner

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

CVS vs. Walgreen's and the latest....

June 12, 2010

As a consultant and clinical pharmacist with over 30 years experience, I am glad someone.... and in this case... Walgreen's finally woke up to fees that are insulting low and a losing proposition. It has been well established the the "average expense to dispense a prescription" (the pharmacy's actual costs including rent, payroll, overhead, etc) is in the $10 range per prescription. Why would any pharmacy sign a contract with a fee of $1.50 per prescription?

Tamper Proof Narcotic Pain pill? YES

November 13, 2008

Analysis of:FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com

This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.

Fosamax generic...

February 11, 2008

Analysis of:Teva wins FDA OK to sell generic Fosamax | www.reuters.com

It is important to understand the generic implications when it comes to drug product olacement on the formulary.

Zyprexa safety

February 11, 2008

Analysis of:FDA Advisory Committee Supports Efficacy and Safety of Zyprexa | www.fiercebiotech.com

This article is informative because it draws conclusions about Zyprexa.

daily use Cialis---a good idea!

January 11, 2008

Analysis of:Cialis Is Cleared for Daily Use | online.wsj.com

Physicians have been prescribing lower dose Cialis...off label... for a long time. The FDA finally agreed and approved it.

A can of tennis balls?

October 19, 2007

Analysis of:Pfizer Abandons Exubera, Posts 77% Earnings Decline | online.wsj.com

Exubera is a great product. However, the delivery system was difficult to use and educate the patients how to use. Hopefully, the next generation of the product will be in a smaller more user friendly cannister.

Diabetes.....

October 7, 2007

Analysis of:Burden of diabetes care rivals disease complications | www.reuters.com

I know that Pfizer finally came out with the inhaled insulin after many years of hype. Unfortunately its launch and the product has been a flop, primarily because of the size if the inhaler. It is large and looks like a can of tennis balls. It is difficult for the patient to understand the dosing and usage as well. However, it was a good try for a first generation product. I think our country is getting better at managing diabetes with the new onset of drugs available.

Overprescribing Tamiflu??

October 7, 2007

Analysis of:Researchers warn about overprescribing Tamiflu | www.reuters.com

I disagree with the Reuters article. Tamiflu is a safe and effective drug for the young and elderly population.

Soma re-visited??

September 19, 2007

Analysis of:FDA approves SOMA 250 mg | www.pipelinereview.com

Soma has been around for many years. Now we have a new strength? Probably because there is no generic available on the 250mg.

Ban DTC advertising

May 15, 2007

Analysis of:Time to Ban Direct-to-Consumer Prescription Drug Marketing | www.medscape.com

Patients may have little understanding of a particular disease state or how to treat it, but with TV advertising they are asking their physicians to prescribe a particular advertised product which is usually quite expensive. There are usually comparable treatments available at a lower cost.

Page : 11 to 10 of 10

Subscribe to Updates

By RSS